Efficacy and safety of lurbinectedin (PM1183) in small cell lung cancer (SCLC): Results from a phase 2 study.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 8570-8570 ◽  
Author(s):  
Jose Manuel Trigo Perez ◽  
Alexandra Leary ◽  
Benjamin Besse ◽  
Daniel E. Castellano ◽  
Santiago Ponce Aix ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Phase 2 Study

scholarly journals Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer withFGFR1amplification: A single-arm, phase 2 study

Cancer ◽  
2016 ◽  
Vol 122 (19) ◽  
pp. 3024-3031 ◽  
Author(s):  
Sung Hee Lim ◽  
Jong-Mu Sun ◽  
Yoon-La Choi ◽  
Hye Ryun Kim ◽  
Soomin Ahn ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Phase 2 Study ◽  
Pretreated Patients

Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer

Lung Cancer ◽  
2012 ◽  
Vol 76 (1) ◽  
pp. 78-83 ◽  
Author(s):  
Benjamin Besse ◽  
David Planchard ◽  
Anne-Sophie Veillard ◽  
Laurent Taillade ◽  
David Khayat ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document